Daniel L. Menichella, Chief Executive Officer at Kaleido Biosciences, Inc. (KLDO), bought 20,000 shares at $11.50 ($230K) on 2021-02-08, disclosed to the SEC on 2021-02-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| V9SNS*IJ | SELL | 2010-09-01 | $2.2M | — | Filing → |